La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Keywords » - entrée « Dopaminergic Neurons (metabolism) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Dopaminergic Neurons (enzymology) < Dopaminergic Neurons (metabolism) < Dopaminergic Neurons (pathology)  Facettes :

List of bibliographic references indexed by Dopaminergic Neurons (metabolism)

Number of relevant bibliographic references: 27.
[0-20] [0 - 20][0 - 27][20-26][20-40]
Ident.Authors (with country if any)Title
000284 (2016) Enkhjargal Bayarsaikhan [Corée du Sud, Mongolie] ; Delger Bayarsaikhan [Corée du Sud] ; Jaesuk Lee [Corée du Sud] ; Myeongjoo Son [Corée du Sud] ; Seyeon Oh [Corée du Sud] ; Jeongsik Moon [Corée du Sud] ; Hye-Jeong Park [Corée du Sud] ; Arivazhagan Roshini [Corée du Sud] ; Seung U. Kim [Canada] ; Byoung-Joon Song [États-Unis] ; Seung-Mook Jo [Corée du Sud] ; Kyunghee Byun [Corée du Sud] ; Bonghee Lee [Corée du Sud]Microglial AGE-albumin is critical for neuronal death in Parkinson’s disease: a possible implication for theranostics
000296 (2016) P. Githure M Ngale ; Brian E. StaveleyLoss of porin function in dopaminergic neurons of Drosophila is suppressed by Buffy
000446 (2016) E M Merzetti [Canada] ; B E Staveley [Canada]Altered expression of CG5961, a putative Drosophila melanogaster homologue of FBXO9, provides a new model of Parkinson disease.
000573 (2015) M. Yue [États-Unis] ; K. Hinkle [États-Unis] ; P. Davies [Royaume-Uni] ; E. Trushina [États-Unis] ; F. Fiesel [États-Unis] ; T. Christenson [États-Unis] ; A. Schroeder [États-Unis] ; L. Zhang [États-Unis] ; E. Bowles [États-Unis] ; B. Behrouz [États-Unis] ; S. Lincoln [États-Unis] ; J. Beevers [États-Unis] ; A. Milnerwood [Canada] ; A. Kurti [États-Unis] ; P. J. Mclean [États-Unis] ; J. D. Fryer [États-Unis] ; W. Springer [États-Unis] ; D. Dickson [États-Unis] ; M. Farrer [Canada] ; H. Melrose [États-Unis]Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock in mice
000587 (2015) Abid Oueslati [Suisse, Canada] ; Blaise Lovisa [Suisse] ; John Perrin [Suisse] ; Georges Wagnières [Suisse] ; Hubert Van Den Bergh [Suisse] ; Yanik Tardy [Suisse] ; Hilal A. Lashuel [Suisse, Qatar]Photobiomodulation Suppresses Alpha-Synuclein-Induced Toxicity in an AAV-Based Rat Genetic Model of Parkinson’s Disease
000629 (2015) Jinghua Liu ; Arjun H. Banskota ; Alan T. Critchley ; Jeff Hafting ; Balakrishnan PrithivirajNeuroprotective Effects of the Cultivated Chondrus crispus in a C. elegans Model of Parkinson’s Disease
000643 (2015) Angela Anderegg [États-Unis] ; Jean-Francois Poulin [États-Unis] ; Rajeshwar Awatramani [États-Unis]Molecular heterogeneity of midbrain dopaminergic neurons--Moving toward single cell resolution.
000648 (2015) Yueting Shao [Canada] ; Daniel Figeys ; Zhibin Ning ; Ryan Mailloux ; Hing Man ChanMethylmercury can induce Parkinson's-like neurotoxicity similar to 1-methyl-4- phenylpyridinium: a genomic and proteomic analysis on MN9D dopaminergic neuron cells.
000745 (2015) Filsy Samuel ; William P. Flavin ; Sobia Iqbal ; Consiglia Pacelli ; Sri Dushyaanthan Sri Renganathan ; Louis-Eric Trudeau ; Edward M. Campbell [États-Unis] ; Paul E. Fraser ; Anurag Tandon [Canada]Effects of Serine 129 Phosphorylation on α-Synuclein Aggregation, Membrane Association, and Internalization*
000789 (2015) Christina Poetschke [Allemagne] ; Elena Dragicevic [Allemagne] ; Johanna Duda [Allemagne] ; Julia Benkert [Allemagne] ; Antonios Dougalis [Allemagne] ; Roberta Dezio [Allemagne] ; Terrance P. Snutch [Canada] ; Joerg Striessnig [Autriche] ; Birgit Liss [Allemagne]Compensatory T-type Ca2+ channel activity alters D2-autoreceptor responses of Substantia nigra dopamine neurons from Cav1.3 L-type Ca2+ channel KO mice
000851 (2015) Beryl Luk [Canada] ; Mohinuddin Mohammed [Canada] ; Fang Liu [Canada] ; Frank J. S. Lee [Canada]A Physical Interaction between the Dopamine Transporter and DJ-1 Facilitates Increased Dopamine Reuptake
000855 (2015) Eric M. Merzetti ; Brian E. Staveleyspargel, the PGC-1α homologue, in models of Parkinson disease in Drosophila melanogaster
000936 (2014) Leigh Christopher [Canada] ; Sarah Duff-Canning [Canada] ; Yuko Koshimori [Canada] ; Barbara Segura [Canada, Espagne] ; Isabelle Boileau [Canada] ; Robert Chen [Canada] ; Anthony E. Lang [Canada] ; Sylvain Houle [Canada] ; Pablo Rusjan [Canada] ; Antonio P. Strafella [Canada]Salience Network and Parahippocampal Dopamine Dysfunction in Memory-Impaired Parkinson Disease
000959 (2014) Jackalina M. Van Kampen [Canada] ; David Baranowski [Canada] ; Denis G. Kay [Canada]Progranulin Gene Delivery Protects Dopaminergic Neurons in a Mouse Model of Parkinson’s Disease
000A10 (2014) Penelope J. Hallett [États-Unis] ; Oliver Cooper [États-Unis] ; Damaso Sadi [Canada] ; Harold Robertson [Canada] ; Ivar Mendez [Canada] ; Ole Isacson [États-Unis]Long-term dopamine transporter expression and normal cellular distribution of mitochondria in dopaminergic neuron transplants in Parkinson’s disease patients
000A47 (2014) Jeffrey Graham [Canada] ; Douglas Hobson [Canada] ; Arjuna Ponnampalam [Canada]High affinity hemoglobin and Parkinson's disease.
000B04 (2014) Jean-Francois Poulin ; Jian Zou ; Janelle Drouin-Ouellet [Royaume-Uni] ; Kwang-Youn A. Kim ; Francesca Cicchetti ; Rajeshwar B. AwatramaniDefining midbrain dopaminergic neuron diversity by single-cell gene profiling
000B12 (2014) Anne-Marie Arel-Dubeau [Canada] ; Fanny Longpré [Canada] ; Julie Bournival [Canada] ; Cindy Tremblay [Canada] ; Julie Demers-Lamarche [Canada] ; Pavlina Haskova [Canada, République tchèque] ; Everaldo Attard [Malte] ; Marc Germain [Canada] ; Maria-Grazia Martinoli [Canada]Cucurbitacin E Has Neuroprotective Properties and Autophagic Modulating Activities on Dopaminergic Neurons
000C37 (2013) Kelvin C. Luk [Canada] ; Vladimir V. Rymar ; Pepijn Van Den Munckhof ; Stefan Nicolau ; Claude Steriade ; Panojot Bifsha ; Jacques Drouin ; Abbas F. SadikotThe transcription factor Pitx3 is expressed selectively in midbrain dopaminergic neurons susceptible to neurodegenerative stress.
000C97 (2013) Matthew P. Mount ; Yi Zhang ; Mandana Amini ; Steve Callaghan ; Jerzy Kulczycki ; Zixu Mao ; Ruth S. Slack ; Hymie Anisman ; David S. ParkPerturbation of Transcription Factor Nur77 Expression Mediated by Myocyte Enhancer Factor 2D (MEF2D) Regulates Dopaminergic Neuron Loss in Response to 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)*
001133 (2012) Maria Xilouri [Grèce] ; Elli Kyratzi ; Pothitos M. Pitychoutis ; Zoi Papadopoulou-Daifoti ; Celine Perier ; Miquel Vila ; Matina Maniati ; Ayse Ulusoy ; Deniz Kirik ; David S. Park ; Keiji Wada ; Leonidas StefanisSelective neuroprotective effects of the S18Y polymorphic variant of UCH-L1 in the dopaminergic system.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Dopaminergic Neurons (metabolism)" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Dopaminergic Neurons (metabolism)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Dopaminergic Neurons (metabolism)
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022